Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study

Xue Zhong(Central South University), Xiaohong Zhang(Harbin Engineering University), Lin Huang(Sun Yat-sen University), Chao Wang(Sunnybrook Health Science Centre), Tianyi Li(Institute of Microbiology), Jing He(Gansu University of Traditional Chinese Medicine), Yue Zhao(Jinyintan Hospital)
Frontiers in Pharmacology
December 6, 2023
10.3389/fphar.2023.1288402
Cited by 1

Related Papers

RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2023|892
HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin
|Molecular Cell|2007|731
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
A review of carbon dots in synthesis strategy
|Coordination Chemistry Reviews|2023|559